|
|
||||||||
The Journal of Immunology, Vol 144, Issue 6 2409-2412, Copyright © 1990 by American Association of Immunologists
ARTICLES |
B Bottazzi, E Erba, N Nobili, F Fazioli, A Rambaldi and A Mantovani
Istituto di Richerche Farmacologiche Mario Negri, Milano, Italy.
Tumor-associated macrophages (TAM) isolated from two murine sarcomas (mFS6 and MN/MCA1) had high levels of proliferative activity (7 to 11% of cells in S phase) compared to peritoneal macrophages (1 to 2% of cells in S phase). In an effort to elucidate the mechanisms responsible for the proliferative activity of TAM, expression of c-fms and macrophage (M)-CSF was investigated in TAM and sarcoma cells. TAM had high levels of mRNA transcripts of the c-fms protooncogene, which encodes a tyrosine kinase probably identical to the M-CSF receptor, but did not express M-CSF transcripts whereas sarcoma cells had high levels of M-CSF mRNA. Sarcoma cell conditioned medium had M-CSF activity on bone marrow cells and induced proliferation of peritoneal exudate and bone marrow-derived macrophages. These activities were blocked by anti- M-CSF antibodies. These findings outline a paracrine circuit in the regulation of TAM proliferation, involving M-CSF, secreted by sarcoma cells and acting on c-fms expressing TAM. Inasmuch as TAM from these murine sarcomas have tumor growth promoting activity, a "ping pong" reciprocal feeding interaction may occur between macrophages and neoplastic cells in these tumors.
This article has been cited by other articles:
![]() |
E. RICHARDSEN, S. W. SORBYE, J. P. CROWE, J.-L. YANG, and L.-T. BUSUND Expression of M-CSF and CSF-1R Is Correlated with Histological Grade in Soft Tissue Tumors Anticancer Res, October 1, 2009; 29(10): 3861 - 3866. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Jadus, C. C. Williams, M. D. Avina, M. Ly, S. Kim, Y. Liu, R. Narasaki, C. A. Lowell, and H. T. Wepsic Macrophages Kill T9 Glioma Tumor Cells Bearing the Membrane Isoform of Macrophage Colony Stimulating Factor Through a Phagocytosis-Dependent Pathway J. Immunol., January 1, 1998; 160(1): 361 - 368. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |